FDA's 2023 decision to place 19 peptides on “unsafe” list was supported by numerous documented safety concerns.
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results